Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...

(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva ...

The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.

Experts debate which patients with stage III dMMR colon cancer will benefit from the two treatment approaches.

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Thursday before the bell. Here’s what ...

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

Novo Nordisk remains a strong buy despite share price dip, thanks to its robust drug pipeline, massive market potential, and ...

Eli Lilly is investing up to $4 billion in the Bristol project and Wisconsin plans to provide up to $100 million in ...

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

Eli Lilly and Co.'s Kenosha County project will be eligible for the largest tax break ever under the state of Wisconsin's ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

The amount of credits the company receives is contingent upon its meeting job creation and capital investment goals.